• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Large owner Sands Lawrence M. acquired 2,500 shares (SEC Form 4)

    8/26/24 6:00:12 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care
    Get the next $VSEE alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Sands Lawrence M.

    (Last) (First) (Middle)
    980 N FEDERAL HWY
    #304

    (Street)
    BOCA RATON FL 33432

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    VSEE HEALTH, INC. [ VSEE ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    08/20/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 08/20/2024 J(1) 2,500 A $0 502,500 I(2) See footnote 1.
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Shares issued pursuant to agreement with SCS, LLC dba SandsConsults ("SCS").
    2. Shares held by SCS of which Reporting Person is the sole manager and sole member. As such, he has sole voting and investment power with respect to Issuer's securities held by SCS. Mr. Sands disclaims beneficial ownership of such securities other than to the extent of his pecuniary interest, if any, therein, directly or indirectly.
    Remarks:
    /s/ Lawrence Sands 08/26/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $VSEE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VSEE

    DatePrice TargetRatingAnalyst
    2/24/2025$5.00Buy
    Maxim Group
    More analyst ratings

    $VSEE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing

      VSee Health, Inc. (the "Company") (NASDAQ:VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock or its public warrants on The Nasdaq Capital Market.

      5/30/25 4:07:00 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • VSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote Philippines

      VSee Health, Inc. (NASDAQ:VSEE), a leader in digital health solutions, customized virtual health workflow integration, and real-time health data analytics, announces the launch of Project MAMA (Mom's AI for Maternity Aid), an innovative telehealth initiative to reduce high maternal mortality rates in rural, isolated Philippines communities of Zamboanga Sibugay. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250516245654/en/Local clinic staff performs a prenatal checkup using the VSee telemedicine kit and digital health platform. Working with maternal care physicians and specialists from Stanford University and Ateneo de Zamboanga

      5/16/25 8:23:00 AM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • VSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing

      VSee Health, Inc. (the "Company") (NASDAQ:VSEE), announced today that on April 25, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2024 (the "Form 10-K"), the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock or its public warrants on The Nasdaq Capital Market. According to the notice, the Company has 60 calendar days

      5/12/25 4:10:00 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care

    $VSEE
    SEC Filings

    See more
    • SEC Form 8-K filed by VSee Health Inc.

      8-K - VSEE HEALTH, INC. (0001864531) (Filer)

      5/30/25 5:01:08 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • SEC Form 8-K filed by VSee Health Inc.

      8-K - VSEE HEALTH, INC. (0001864531) (Filer)

      5/8/25 5:04:24 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • SEC Form NT 10-K filed by VSee Health Inc.

      NT 10-K - VSEE HEALTH, INC. (0001864531) (Filer)

      3/31/25 9:15:57 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care

    $VSEE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $VSEE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Maxim Group initiated coverage on VSee Lab with a new price target

      Maxim Group initiated coverage of VSee Lab with a rating of Buy and set a new price target of $5.00

      2/24/25 8:42:03 AM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • Co-CEO Aisiku Imoigele disposed of 120,000 shares, decreasing direct ownership by 3% to 3,416,990 units (SEC Form 4)

      4 - VSEE HEALTH, INC. (0001864531) (Issuer)

      11/19/24 8:57:01 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • Large owner Sands Lawrence M. acquired $405,000 worth of shares (202,500 units at $2.00) (SEC Form 4)

      4 - VSEE HEALTH, INC. (0001864531) (Issuer)

      11/19/24 8:55:08 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • Large owner Sands Lawrence M. acquired 2,500 shares (SEC Form 4)

      4 - VSEE HEALTH, INC. (0001864531) (Issuer)

      8/26/24 6:00:12 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care

    $VSEE
    Financials

    Live finance-specific insights

    See more
    • VSee Health Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / December 20, 2024 / RedChip Companies will air an interview with VSee Health, Inc. (NASDAQ:VSEE) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, December 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interview in its entirety at: https://www.redchip.com/assets/access/vsee_accessIn an exclusive interview, Milton Chen, PhD, co-CEO of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated solutions position the company as a growing leader in the $787 billion telehealth

      12/20/24 9:00:00 AM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (NASDAQ:VSEE) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:VSEE: https://www.redchip.com/assets/access/vsee_accessSXTP: https://www.redchip.com/assets/access/sxtp_accessIn an exclusive interview, Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated so

      12/2/24 4:05:00 PM ET
      $SXTP
      $VSEE
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Medical/Nursing Services

    $VSEE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

      SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

      11/14/24 8:45:14 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

      SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

      11/14/24 5:23:34 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by VSee Health Inc.

      SC 13G - VSEE HEALTH, INC. (0001864531) (Subject)

      7/5/24 4:29:01 PM ET
      $VSEE
      Medical/Nursing Services
      Health Care